Financials Stille AB

Equities

STIL

SE0000998650

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 12:00:00 2024-06-20 EDT 5-day change 1st Jan Change
217 SEK +0.93% Intraday chart for Stille AB +0.93% +43.71%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 444.1 754.5 561.5 757 1,950 - -
Enterprise Value (EV) 1 444.1 754.5 527.8 757 1,864 1,742 1,652
P/E ratio - 46.9 x - - 26 x 18.7 x 16.2 x
Yield - - - - 1.27% 1.54% 1.75%
Capitalization / Revenue 3.11 x - 2.28 x 2.57 x 3.49 x 3.11 x 2.81 x
EV / Revenue 3.11 x - 2.14 x 2.57 x 3.34 x 2.78 x 2.38 x
EV / EBITDA - - 12.5 x 12.1 x 15.4 x 10.7 x 8.98 x
EV / FCF - - 22.1 x 31.1 x -6.78 x 16.3 x 13.4 x
FCF Yield - - 4.53% 3.22% -14.8% 6.14% 7.44%
Price to Book - - - - 2.75 x 2.49 x 2.24 x
Nbr of stocks (in thousands) 4,828 5,013 5,013 5,013 8,985 - -
Reference price 2 92.00 150.5 112.0 151.0 217.0 217.0 217.0
Announcement Date 21-02-18 22-02-17 23-02-17 24-02-16 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 142.6 - 246.4 294.9 558.7 627.2 694.3
EBITDA 1 - - 42.1 62.6 120.7 163.3 183.9
EBIT 1 - - 32.41 48.3 93.39 133.7 152.7
Operating Margin - - 13.15% 16.38% 16.72% 21.31% 21.99%
Earnings before Tax (EBT) 1 - - - - 97 135.5 156.3
Net income 1 8.273 16.1 - - 75.02 104.3 120.3
Net margin 5.8% - - - 13.43% 16.63% 17.33%
EPS 2 - 3.210 - - 8.349 11.61 13.39
Free Cash Flow 1 - - 23.9 24.37 -275 107 123
FCF margin - - 9.7% 8.27% -49.22% 17.06% 17.71%
FCF Conversion (EBITDA) - - 56.76% 38.94% - 65.53% 66.87%
FCF Conversion (Net income) - - - - - 102.59% 102.23%
Dividend per Share 2 - - - - 2.750 3.350 3.800
Announcement Date 21-02-18 22-02-17 23-02-17 24-02-16 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 61.6 63.3 - 61.84 - 75.09 70.11 77.3 139.7 140.6 133.4 145.1
EBITDA 1 9.8 11.2 - - - 15.7 15.5 17.7 17 32.98 32.87 37.94
EBIT 1 7.5 8.9 - - - 11.95 11.92 14 10.3 26.08 26.17 30.85
Operating Margin 12.18% 14.06% - - - 15.91% 17.01% 18.11% 7.37% 18.56% 19.61% 21.27%
Earnings before Tax (EBT) 1 - - - - - - - - - 27.5 25.72 28.7
Net income 1 - - 6.514 - 3.417 - - - - 21.04 19.67 21.96
Net margin - - - - - - - - - 14.97% 14.74% 15.14%
EPS 2 - - 1.300 - 0.6800 - - - - 2.342 2.189 2.444
Dividend per Share - - - - - - - - - - - -
Announcement Date 22-04-28 22-07-15 22-10-27 23-02-17 23-04-27 23-07-14 23-10-26 24-02-16 24-04-25 - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - 33.7 - 85.5 208 298
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - 23.9 24.4 -275 107 123
ROE (net income / shareholders' equity) - - 16.2% - 11.2% 14% 14.6%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - - - 78.80 87.10 96.70
Cash Flow per Share - - - - - - -
Capex 1 - - 2.13 1.41 16.1 12.3 20.4
Capex / Sales - - 0.86% 0.48% 2.88% 1.95% 2.94%
Announcement Date 21-02-18 22-02-17 23-02-17 24-02-16 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
217 SEK
Average target price
231.5 SEK
Spread / Average Target
+6.68%
Consensus